Wealthedge Investment Advisors »

Scpharmaceuticals shares owned by Wealthedge Investment Advisors

Quarter-by-quarter ownership of Scpharmaceuticals (SCPH) shares owned by Wealthedge Investment Advisors from 13F filings

Historical chart of Wealthedge Investment Advisors investment in Scpharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Scpharmaceuticals held by Wealthedge Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Scpharmaceuticals by Wealthedge Investment Advisors

Quarter filed Position value Share count Share price at filing
2025-06-30 $139k 37k 3.81
2025-03-31 $171k 65k 2.63
2024-12-31 $69k 19k 3.54

More positions owned by Wealthedge Investment Advisors

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Pimco Etf Tr 15+ Yr Us Tips (LTPZ)
Microsoft Corporation (MSFT)
Agf Invts Tr Us Market Netrl (BTAL)
Ishares Tr Core S&p500 Etf (IVV)
NVIDIA Corporation (NVDA)
Vanguard Index Fds Mid Cap Etf (VO)
Apple (AAPL)
Schwab Strategic Tr Us Tips Etf (SCHP)
Janus Detroit Str Tr Hendrson Aaa Cl (JAAA)
Vanguard Index Fds Value Etf (VTV)
Schwab Strategic Tr Us Lcap Gr Etf (SCHG)
Ishares Tr 0-3 Mnth Treasry (SGOV)
Ishares Tr Russell 2000 Etf (IWM)
Bristol Myers Squibb (BMY)

View all positions for Wealthedge Investment Advisors

Top funds holding Scpharmaceuticals

OrbiMed Advisors
Rubric Capital Management
Weiss Asset Management LP[1
BlackRock
Tudor Investment Corporation
Luther King Capital Management Corporation
Hsbc Holdings
Glazer Capital
Alpine Associates Management
Newtyn Management
Geode Capital Management
Nantahala Capital Management
State Street Corporation
Nomura Holdings
Perceptive Advisors

View all funds holding Scpharmaceuticals